According to the report, the global rare neurodegenerative disease treatment market was valued at US$ 67 Bn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030.
Rare Neurodegenerative Disease Treatment Market: Introduction
According to the report, the global rare neurodegenerative disease treatment market was valued at US$ 67 Bn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030. Various types of neurological disorders are epilepsy, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, cerebrovascular diseases, and others. The different types of drug class to treat neurology disorders are anticholinergic, antiepileptic, antipsychotic, hypnotic & sedative, analgesics, antihypertensive, anticoagulants, and others. In terms of indication, the global rare neurodegenerative disease treatment market has been classified into multiple sclerosis (MS), Alzheimer’s disease, Parkinson’s disease, acute migraine, autism, narcolepsy, amyotrophic lateral sclerosis (ALS), attention deficit hyperactivity disorder (ADHD), spinal muscular atrophy, Tourette syndrome, Huntington’s disease, and others. The multiple sclerosis (MS) segment captured the largest market share in 2019. The segment is expected to be driven by rise in number of patients with multiple sclerosis and increase in awareness about the disorder.
Read Report Overview - https://www.transparencymarketresearch.com/rare-neurodegenerative-disease-treatment-market.html
Based on drug class, the global rare neurodegenerative disease treatment market has been categorized into neurotransmitter agents, neuroprotective agents, biologics, and others. The neuroprotective agents segment held major share of the global market in 2019. In terms of distribution channel, the global rare neurodegenerative disease treatment market has been divided into hospital pharmacies, online pharmacies, and retail pharmacies. The hospital pharmacies segment accounted for the leading share of the market in 2019. Large inventory maintained by hospitals and availability of essential drugs at hospital pharmacies are likely to drive the segment.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=78468
Rare Neurodegenerative Disease Treatment Market: Prominent Regions
North America held a major share of the global rare neurodegenerative disease treatment market in 2019. Recent product approvals & launch of new drugs and presence of prominent pharmaceutical companies offering therapeutic products for the treatment of rare neurological disorders are key factors driving the market in the region. Increase in healthcare expenditure also contributes to the growth of the market in North America. Europe held the second largest share of the global rare neurodegenerative disease treatment market in 2019. The growth of the rare neurodegenerative disease treatment market in the region can be attributed to the rise in the number of patients with rare neurological conditions and increase in R&D expenditure.
Request for Analysis of COVID-19 Impact on Rare Neurodegenerative Disease Treatment Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=78468
Rare Neurodegenerative Disease Treatment Market: Key Players
Leading players are expanding their footprint to strengthen their positions in the global rare neurodegenerative disease treatment market. Promising drug candidates in pipeline and increase in research & development efforts by big pharmaceutical companies are likely to present lucrative opportunities in the global rare neurodegenerative disease treatment market. Hence, manufacturers engage in new product development, collaborations, and distribution to gain market share. Key players operating in the global rare neurodegenerative disease treatment market include Allergan plc, Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer, Inc., Sanofi, and Teva Pharmaceutical Industries Ltd.
Browse More Trending Reports by Transparency Market Research:
Advanced Bone Grafts Market: https://www.transparencymarketresearch.com/advanced-bone-grafts-market.html
Dermatoscope Market: https://www.transparencymarketresearch.com/dermatoscope-market.html
Medical Computer Carts Market: https://www.transparencymarketresearch.com/medical-computer-carts-market.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453